NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | - | - | - | ₹-0.90 Cr | ₹-0.86 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2013 | ₹-0.90 Cr |
Mar2012 | ₹-0.86 Cr |
How is Deferred Tax Assets / Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 100.00 | |
Mar2013 | ₹-0.90 Cr | Negative | |
Mar2012 | ₹-0.86 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹375.3 Cr | -4.4% | 3.4% | -0.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,113.6 Cr | -4% | -5% | 14.3% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,403.9 Cr | -4.2% | -15% | 33.8% | Stock Analytics | |
VENKYS (INDIA) | ₹2,255.7 Cr | -1.3% | -0.4% | -21.3% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,418.8 Cr | -3.9% | -1.8% | -30.6% | Stock Analytics | |
INDO US BIOTECH | ₹303.6 Cr | 0.4% | 2.2% | -30.7% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -4.4% |
3.4% |
-0.8% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses